Sangamo Therapeutics
SGMO
SGMO
145 hedge funds and large institutions have $869M invested in Sangamo Therapeutics in 2014 Q1 according to their latest regulatory filings, with 39 funds opening new positions, 51 increasing their positions, 39 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
26% more funds holding
Funds holding: 115 → 145 (+30)
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
Holders
145
Holding in Top 10
3
Calls
$250M
Puts
$25.4M
Top Buyers
| 1 | +$32.9M | |
| 2 | +$23.8M | |
| 3 | +$19.8M | |
| 4 |
Invesco
Atlanta,
Georgia
|
+$14.8M |
| 5 |
PA
Perceptive Advisors
New York
|
+$14.5M |
Top Sellers
| 1 | -$22.5M | |
| 2 | -$20.3M | |
| 3 | -$14.7M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$13.6M |
| 5 |
SCA
SAC Capital Advisors
Stamford,
Connecticut
|
-$11.1M |